Skip to main content
. 2021 Oct 1;131(19):e149336. doi: 10.1172/JCI149336

Figure 3. Progressive long-term lung remodeling after SeV infection.

Figure 3

(A) Immunostaining for Aqp3, Krt5, Sftpc, and Pdpn with DAPI counterstaining in lung sections 49 days after SeV or SeV-UV infection. Scale bar: 1 mm. (B) Immunostaining for Aqp3 and Pdpn in lung sections 0–49 days after SeV infection. Scale bar: 1 mm. (C) Immunostaining of bronchiolar-alveolar remodeling sections under the conditions in B. Scale bar: 400 μm. Original magnification, ×3.5 (inset). (D) Immunostaining for Sftpc and Pdpn in lung alveolar sections 0–49 days after SeV. Scale bar: 200 μm. (E) Immunostaining for Aqp3 in lung bronchiolar-alveolar sections 49 days after SeV infection. Scale bar: 400 μm. (F) Immunostaining for Sftpc 0–49 days after SeV infection. Scale bar: 200 μm. (G) Quantitation of immunostaining for Aqp3, Krt5, Sftpc, and Pdpn in lung sections 0–49 days after SeV infection. Data represent results from a single experiment with 5 mice per condition and were replicated twice.